Document Detail


Omega-3 fatty acids and inflammatory bowel diseases - a systematic review.
MedLine Citation:
PMID:  22591898     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background & Aim: Despite their well known anti-inflammatory actions, the clinical usefulness of omega-3 PUFA in inflammatory bowel disease is controversial. We aimed to systematically review the available data on the performance of omega-3 PUFA as therapeutic agents in these patients. Methods: Electronic databases were systematically searched for RCT of fish oil or omega-3 PUFA therapy in both active and inactive ulcerative colitis or Crohn's disease, without limitation on either the length of therapy or the form it was given, including nutritional supplements and enteral formula diets. Eligible articles were assessed for methodological quality on the basis of the adequacy of the randomisation process, concealment of allocation, blinding of intervention and outcome, possible biases, and completeness of follow-up. The five-point Oxford quality score was calculated. Results: A total of 19 RCT were finally selected for this review. Overall, available data do not allow to support the use of omega-3 PUFA supplementation for the treatment of both active and inactive inflammatory bowel disease. Negative results are quite consistent in trials assessing the use of omega-3 PUFA to maintain disease remission, particularly ulcerative colitis, and to a lesser extent Crohn's disease. Trials on their use in active disease do not allow to draw firm conclusions mainly because the heterogeneity of design (ulcerative colitis) or their short number (Crohn's disease). In most trials, the appropriateness of the selected placebo is questionable. Conclusion: The present systematic review does not allow to make firm recommendations about the usefulness of omega-3 PUFA in inflammatory bowel disease.
Authors:
Eduard Cabré; Míriam Mañosa; Miquel A Gassull
Related Documents :
9739498 - Is aging a preventable or curable disease?
2787218 - Laryngeal papillomatosis: analysis of 113 patients.
18333478 - Host susceptibility hypothesis for shell disease in american lobsters.
23975618 - Plasma extracellular vesicle protein content for diagnosis and prognosis of global card...
11371748 - Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional conse...
18090678 - Cardiovascular disease in dialysis patients: do some antihypertensive drugs have specif...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The British journal of nutrition     Volume:  107 Suppl 2     ISSN:  1475-2662     ISO Abbreviation:  Br. J. Nutr.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372547     Medline TA:  Br J Nutr     Country:  England    
Other Details:
Languages:  eng     Pagination:  S240-52     Citation Subset:  IM    
Affiliation:
IBD Unit, Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Ctra. del Canyet s/n, 08916 Badalona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dietary sources of omega 3 fatty acids: public health risks and benefits.
Next Document:  A systematic review of omega-3 fatty acids and osteoporosis.